Skip to main content
PRVA logo

PRVA · Privia Health Group, Inc. · Analyst Estimates

Track PRVA — free
$19.69 +0.07 (+0.36%) At close · Sep 30
Market Cap
$2.52B
Shares
127.73M
Volume · Sep 30 1.34M Avg daily vol (3M) 1.22M

Analyst Estimates

Compare analyst forecasts for Privia Health Group, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-27 06:18 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
0.77
0.884
1.24
—
0.8758
0.95114
0.8758
0.95221
— — — —
EPS
analysts
Publication date not stated
— — —
10
— — — —
7
6
3
3
Revenue
USD
Publication date not stated
2417300000
2457057960
2504000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
14
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
0.85
1.061
1.36
—
1.0634
1.09748
1.0634
1.09736
— — — —
EPS
analysts
Publication date not stated
— — —
10
— — — —
5
4
5
5
Revenue
USD
Publication date not stated
2536000000
2695888540
2853971000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
14
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
0.18
0.24333
0.32
—
0.24117
0.2585
0.24117
0.26031
— — — —
EPS
analysts
Publication date not stated
— — —
9
— — — —
4
4
5
4
Revenue
USD
Publication date not stated
584900000
609165520
650069000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
13
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
0.18
0.24333
0.33
—
0.23845
0.24725
0.23845
0.25058
— — — —
EPS
analysts
Publication date not stated
— — —
9
— — — —
2
2
6
5
Revenue
USD
Publication date not stated
592600000
607796320
630093000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
13
— — — — — — — —
Key facts CIK 1759655 CUSIP 74276R102 13F (30d) 13 filings 9 filers Visit website Investor relations